Ex-CEO Found Liable For $1 Now Seeks Atty Fees For Del. Suit

By Leslie A. Pappas · June 21, 2024, 6:34 PM EDT

The ex-CEO of a biopharma company who was found liable in 2021 for breaching his fiduciary duties but ordered to pay just $1 in damages after Delaware's Court of Chancery found...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Recent Articles By Leslie

June 25, 2024
Chancery OKs $71M Premier Deal, $14M Four-Firm Fee
June 12, 2024
Directors Of Defunct Med Tech SPAC Seek Toss Of Del. Suit
May 21, 2024
SPAC Investor's Suit Changes Came Too Late, Chancery Rules
May 17, 2024
EndoStim Emerges From Delaware Insolvency Proceeding
May 02, 2024
Investors Not Entitled To Info, Sequel Youth Tells Chancery
May 01, 2024
'Foul' BioVentrix Cash-Out Gets Extra Scrutiny, Chancery Says
April 26, 2024
Therapy Co. SPAC Investors To Settle Del., Ill. Merger Suits
April 17, 2024
Elliott Waives BioMarin Board Deal, Moots Del. Suit
April 11, 2024
Del. Justices OK Denial Of Icahn-Illumina Midcase Appeal Bid
April 02, 2024
Theseus Investor Seeks Appraisal After Concentra Merger